Role of TGF-beta1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima Fatty rats.
Recently established Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of naturally occurring obesity diabetes, exhibit progressive accumulation of connective tissue in the pancreas. The present study was designed to determine the pathogenic role of transforming growth factor-beta1 (TGF-beta1) in the development of pancreatic fibrosis in OLETF rats by investigating the serial changes in the expression of TGF-beta1 and extracellular matrix (ECM) in the pancreas. Progressive proliferation of connective tissue arose from the interstitial region surrounding islets at 20 wk of age and extended to the exocrine pancreas adjacent to the islets. TGF-beta1 mRNA levels in the pancreas increased at 20 wk of age and reached a peak value at 30 wk of age. Fibronectin (FN) and procollagen types I and III mRNAs peaked at 20 wk of age and remained at higher levels than those in the nondiabetic counterparts Long-Evans Tokushima Otsuka rats until 50 wk of age. Immunoreactivities for TGF-beta1 and FN were found in islets of OLETF rats at 20 wk of age and were seen in acinar and interstitial cells at 50 wk of age. Moreover, alpha-smooth muscle actin was located at interstitial region surrounding the islets. Proliferation of the connective tissue in the pancreas of OLETF rats closely correlated with expression of TGF-beta1 and ECM. Our results suggest that the development of pancreatic fibrosis in OLETF rats extends from endocrine to exocrine pancreas and that TGF-beta1 is involved in pancreatic fibrosis of OLETF rats.
Yoshikawa
Hiroyuki
H
Third Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, 807 - 8555 Japan.
Kihara
Yasuyuki
Y
Taguchi
Masashi
M
Yamaguchi
Taizo
T
Nakamura
Hayato
H
Otsuki
Makoto
M
D000199:Actins / Q000032:analysis; D000375:Aging; D000818:Animals; D015152:Blotting, Northern; D024042:Collagen Type I / Q000235:genetics; D024061:Collagen Type III / Q000235:genetics; D003238:Connective Tissue / Q000473:pathology; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000473:pathology; D005109:Extracellular Matrix / Q000473:pathology; D005353:Fibronectins / Q000032:analysis / Q000235:genetics; D005355:Fibrosis; D007150:Immunohistochemistry; D007515:Islets of Langerhans / Q000737:chemistry / Q000473:pathology; D008297:Male; D009765:Obesity; D010179:Pancreas / Q000737:chemistry / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D020334:Rats, Inbred OLETF; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000502:physiology*; D053773:Transforming Growth Factor beta1
D000199:Actins; D024042:Collagen Type I; D024061:Collagen Type III; D005353:Fibronectins; D012333:RNA, Messenger; C508962:Tgfb1 protein, rat; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1